Rizt, thanks for the "welcome". Just to set the record straight, since the spring of 2019 I have posted 155 times on this MB. During that time, I have personally complimented Dr. Pourhassan and thanked him for his hard work many times for getting Cytodyn to this point, .It was incredibly difficult task requiring skills and determination absent in most people. That does not mean, however, that we should not take a hard look at whether or not a different set of skills and knowledge base will necessary to advance Leronlimab to approval.

If shareholders who ask questions and suggest that change may be necessary to achieve the goals are "bashers", then I'm guilty. But, I think if you read my recent Posts carefully, you will not find any personal attacks, name calling, or the like.

I don't think you would want this MB to become a SAFE ZONE for management and/or their supporters. What would be the point? At any rate, I want the company to be successful, just like you. Let's give each other the benefit of the doubt as to our intentions until proven unworthy.